Boston Scientific D&A decreased by 3.8% to $351M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $325M to $351M. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 5.8% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Metric ID:
depreciation_and_amortizationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $263M | $272M | $290M | $274M | $284M | $284M | $294M | $285M | $298M | $300M | $313M | $304M | $311M | $306M | $348M | $325M | $336M | $342M | $365M | $351M |
| QoQ Change | — | +3.4% | +6.6% | -5.5% | +3.6% | +0.0% | +3.5% | -3.1% | +4.6% | +0.7% | +4.3% | -2.9% | +2.3% | -1.6% | +13.7% | -6.6% | +3.4% | +1.8% | +6.7% | -3.8% |
| YoY Change | — | — | — | — | +8.0% | +4.4% | +1.4% | +4.0% | +4.9% | +5.6% | +6.5% | +6.7% | +4.4% | +2.0% | +11.2% | +6.9% | +8.0% | +11.8% | +4.9% | +8.0% |
Range$263M – $365M
CAGR+6.3%
Avg YoY Growth+6.2%
Median YoY Growth+6.0%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular | $71M | $75M | $91M | $78M | $83M | $89M | $105M | $89M |
| MedSurg | $27M | $27M | $31M | $27M | $28M | $29M | $31M | $29M |
| Total | $311M | $306M | $348M | $325M | $336M | $342M | $365M | $351M |
D&A at Other Companies
Frequently Asked Questions
- What is Boston Scientific's d&a?
- Boston Scientific (BSX) reported d&a of $351M in Q1 2026.
- How has Boston Scientific's d&a changed year-over-year?
- Boston Scientific's d&a increased by 8.0% year-over-year, from $325M to $351M.
- What is the long-term trend for Boston Scientific's d&a?
- Over 4 years (2021 to 2025), Boston Scientific's d&a has grown at a 5.8% compound annual growth rate (CAGR), from $1.09B to $1.37B.